Komori
Ono Pharmaceutical (4528) · RiskAdvanced

Risk of Failing to Secure and Develop Diverse, High-Caliber Talent

First written in FY2020. 1 of 3 entries say "Reframed", first in FY2022. Latest entry: FY2026.

3entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2020ReframedFY20222020: 120202021: 020212022: 120222023: 020232024: 020242025: 020252026: 12026
Same theme, other companies
Talent acquisition, development and retention, and labor compliance risksA theme 720 companies write about · 738 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2026: 27 of 104 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 738 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「We aim to secure at least 250 next-generation management personnel, 300 global personnel, 700 digital personnel, including at least 200 personnel capable of planning, managing and executing DX projects and at least 500 personnel capable of participating in and contributing to DX projects, and 180 innovation personnel by fiscal 2026.」

    As progress on human capital KPIs in fiscal 2025, we disclosed 239 next-generation management personnel, 181 global personnel, 1,056 digital personnel, 135 innovation personnel and 411 specialized personnel. We also disclosed a 9.1% ratio of women in management positions, an 88.8% rate of male employees taking childcare leave, and an engagement index of 72.
  2. FY2022ReframedAnnual report

    「Our Group works to secure and develop a diverse and talented workforce to achieve sustainable growth. To enable each diverse employee to work with enthusiasm and maximize their abilities, we are developing support systems and workplace environments that accommodate diverse working styles, seeking to secure human resources through initiatives to become an attractive company where people can find fulfillment in their work, and enhancing training programs aligned with each individual’s growth and capabilities.」

    The response to the risk of securing and developing a diverse and talented workforce has been made concrete through human capital initiatives covering diverse working styles, workplace environments and training programs.
  3. FY2020First statedAnnual report

    「However, if we are unable to secure and develop a diverse and talented workforce over the medium to long term, our Group’s operating results and financial position may be materially affected by stagnation in business activities and other factors.」

    The possibility that a diverse and talented workforce cannot be secured and developed over the medium to long term has been explicitly stated for the first time as a risk associated with measures to develop human capital and promote diversity.
Moved together

"Long-term enhancement of corporate value and alignment of interests with shareholders" moved the same way as this thread, in the same document, in 2 of its 3 moves.

2★1
  1. ★This thread
  2. 1Long-term enhancement of corporate value and alignment of interests with shareholders2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Ono Pharmaceutical's next results are scheduled for 2026-10-29. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.